ProCE Banner Activity

Immunotherapy-Based Combinations in Intermediate HCC


Slides from a live ASCO 2024 live satellite symposium covering the recent developments in the rapidly evolving landscape of intermediate HCC, including individualizing therapy based on Barcelona Clinic Liver Cancer staging, recent trial updates for TACE plus systemic therapy with durvalumab and bevacizumab, and other expert considerations relevant to interventional radiology practice.

Released: May 29, 2024

Expiration: May 28, 2025



Sarah B. White

Sarah B. White, MD, MS, FSIR, FCIRSE

Professor of Radiology and Surgical Oncology
Vice Chair, Radiology Research
Associate Dean/Assistant Provost, Faculty Affairs
Senior Medical Director, Programmatic Excellence
Department of Radiology, Division of Vascular & Interventional Radiology
Medical College of Wisconsin
Milwaukee, Wisconsin

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from AstraZeneca.